Abstract: An intraocular lens having an optic and at least one semi-rigid, haptic connected to the optic, both of which may be acrylic. The intraocular lens can have a fixed longitudinal length, e.g., the same fixed length pre-operatively and post-operatively. The intraocular lens can resist deformation, despite contraction and relaxation of the ciliary muscle and fibrosis within the capsular bag, after implantation into the eye using, for example, by the semi-rigid haptics. The intraocular lens can be sufficiently flexible to be compressed from an original configuration to a compressed configuration for insertion into the eye through a small incision and return to the original configuration after implantation into the eye.
Abstract: An implant includes a collapsible anchor to be deployed within a lumen and a protrusion coupled to the anchor. The protrusion, in a constrained state, extends a distance from an exterior surface of the anchor and, in an unconstrained state, extends further from the exterior surface of the anchor. Also included is a biodegradable constraint, such as a biodegradable tube or suture, configured to maintain the protrusion in the constrained state until the constraint releases. The implant may include additional biodegradable constraints, each constraint configured to maintain the protrusion in a different constrained state and to degrade over a different predetermined period after the implant has been deployed within the lumen. The protrusion may include a bi-directional barb or an open loop. The protrusion may be configured to penetrate a wall of the lumen and to allow tissue to grow about the protrusion.
Type:
Grant
Filed:
August 14, 2014
Date of Patent:
May 9, 2017
Assignee:
GI Dynamics, Inc.
Inventors:
David A. Melanson, Christopher Nutting, Barry Maxwell, Peter Shank, John Panek
Abstract: A device for implanting a prosthesis 12 in a body tissue equipped with a tubular element 7, within which a prosthesis 12 can slide, and a pressure element 16 for moving said prosthesis 12. The device also comprises a cartridge 5 provided with a seat 31 at its interior, such seat housing the prosthesis 12 and movable under the action of a pusher element 13 from a first position, in which the seat 31 is not facing the tubular element 7, to a second position, in which the seat 31 is in communication with the tubular element 7 in order to allow the insertion of the prosthesis 12 inside the tubular element 7 upon command of the pressure element 16.
Abstract: An intraocular lens including a flexible optic and at least one rigid plate haptic connected to the optic. The at least one rigid plate haptic can include a rigid structure. The at least one rigid plate haptic can be resistant to bending from pressure exerted on a distal end of the at least one haptic by contraction of the ciliary muscle. The intraocular lens can be a non-accommodating IOL having a longitudinal length that is fixed and configured to resist deformation by the action of the ciliary muscle. Various embodiments also include accommodating intraocular lenses.
Abstract: The present embodiments provide a method for delivering a stent comprising providing a stent in a delivery state, where the stent comprises a plurality of interconnected strut segments that enable expansion of the stent from a delivery state to a deployed state. Stacking a frontal surface of a first strut segment at least partially behind a rear surface of a second strut segment in the delivery state. Aligning a sharpened tip of a first barb at least partially circumferentially behind at least one strut segment in the delivery state such that the sharpened tip is not radially exposed. Expanding the stent from the delivery state to a deployed state, wherein the first barb is exposed to a patient in the deployed state.
Abstract: A bioactive spinal implant used in cervical fusion, Anterior Lumbar Interbody Fusion (ALIF), Posterior Lumbar Interbody Fusion (PLIF), and Transforaminal Interbody Fusion (TLIF), having properties and geometries that enhance bone contact, stability, and fusion between adjacent vertebral bodies.
Type:
Grant
Filed:
November 9, 2015
Date of Patent:
April 25, 2017
Assignee:
Orthovita, Inc.
Inventors:
Charanpreet S. Bagga, Erik M. Erbe, James P. Murphy, James M. Freid, Gregory J. Pomrink
Abstract: An optical device comprising an optical hydrogel with select regions that have been irradiated with laser light having a pulse energy from 0.01 nJ to 50 nJ and a wavelength from 600 nm to 900 nm. The irradiated regions are characterized by a positive change in refractive index of from 0.01 to 0.06, and exhibit little or no scattering loss. The optical hydrogel is prepared with a hydrophilic monomer.
Type:
Grant
Filed:
December 9, 2014
Date of Patent:
April 18, 2017
Assignee:
University of Rochester
Inventors:
Wayne H. Knox, Li Ding, Jay F. Kunzler, Dharmendra Jani
Abstract: An apparatus, system and method for providing an optical filter for an intraocular lens. The apparatus, system and method may include at least one optical filtering layer applied to at least one surface of the optic, wherein the optical filtering layer may at least partially filter light through the intraocular lens. The at least one optical filtering layer may include different types of optical filters including a neutral density filter, a chromatic filter, a photochromatic filter, and a polarizing filter. These filters may be used to reduce the transmission of light through the intraocular lens.
Type:
Grant
Filed:
March 3, 2014
Date of Patent:
April 18, 2017
Assignee:
Abbott Medical Optics Inc.
Inventors:
Hendrik A. Weeber, Terrence B. Mazer, Marrie H. Van Der Mooren, Kaccie Y. Li, Huawei Zhao
Abstract: Mitral valve prolapse and mitral regurgitation can be treating by implanting in the mitral annulus a transvalvular intraannular band. The band is positioned so that it extends transversely across a coaptive edge formed by the closure of the mitral valve leaflets, to inhibit prolapse into the left atrium. At least one marginal chordae is severed, to permit leaflet closure against the band.
Type:
Grant
Filed:
February 13, 2015
Date of Patent:
April 11, 2017
Assignee:
Heart Repair Technologies, Inc.
Inventors:
Valavanur A. Subramanian, Thomas Afzal, Gary Hulme, Jeffrey Christian, Michael L. Reo
Abstract: An intraocular lens including a flexible optic and at least one rigid plate haptic connected to the optic. The at least one rigid plate haptic can include a rigid structure. The at least one rigid plate haptic can be resistant to bending from pressure exerted on a distal end of the at least one haptic by contraction of the ciliary muscle. The intraocular lens can be a non-accommodating IOL having a longitudinal length that is fixed and configured to resist deformation by the action of the ciliary muscle. Various embodiments also include accommodating intraocular lenses.
Abstract: An apparatus and method for inserting prosthesis implants into a patient pocket. The apparatus includes a universal bellow, prosthesis, and a retractor. The apparatus prevents infection; eases insertion and placement; and reduces complications. In use, the retractor anchors the universal bellow to the patient while allowing the bellow to be manipulated to force the prosthesis into a surgical pocket of a patient.
Abstract: Gluteal implants and gluteal implant systems are described herein, as are methods of manufacturing and implanting the same. In certain embodiments, the gluteal implant includes a body having a convex upper surface, a concave lower surface, and an edge, the edge being formed by the intersection between the convex upper surface and the concave lower surface. The body can take on various shapes, including a truncated ovoid shape, a truncated approximate ovoid shape, a truncated substantially ovoid shape, a truncated ellipsoid shape, a truncated approximate ellipsoid shape, or a truncated substantially ellipsoid shape, among others. In certain embodiments, the gluteal implant system includes first and second gluteal implants that have the same or different shaped bodies. In certain embodiments, the gluteal implants and gluteal implant systems are implanted in a buttock region.
Abstract: Implantable corneal and intraocular implants such as a mask are provided. The mask can improve the vision of a patient, such as by being configured to increase the depth of focus of an eye of a patient. The mask can include an aperture configured to transmit along an optical axis substantially all visible incident light. The mask can further include a transition portion that surrounds at least a portion of the aperture. This portion can be configured to switch from one level of opacity to another level of opacity through the use of a controllably variable absorbance feature such as a switchable photochromic chromophore within a polymer matrix.
Abstract: Synthetic structures for soft tissue repair include a multi-layer planar fibrillar structure having layers which are intermittently secured to each other and which approximates mechanical properties comparable to those of soft tissue. In embodiments, the fibrillar structure possesses an intermittently secured edge portion secured by intermittent welds. In embodiments, the multi layer planar fibrillar structure includes a bioactive agent.
Type:
Grant
Filed:
July 31, 2009
Date of Patent:
March 21, 2017
Assignee:
Synthasome, Inc.
Inventors:
Anthony Ratcliffe, Andreas Kern, Mohammad Sotoudeh, Fatemeh Ratcliffe
Abstract: A gastrointestinal implant device comprises a planar proximal element configured to reside in a stomach to resist distal migration, a distal element configured to reside in an intestine to resist proximal migration and one or more tethers coupling the planar proximal element to the distal element.
Type:
Grant
Filed:
July 12, 2013
Date of Patent:
March 21, 2017
Assignee:
GI Dynamics, Inc.
Inventors:
Andres Chamorro, III, Andy H. Levine, David A. Melanson, Barry Maxwell, Richard A. Gambale
Abstract: A stent for use in a prosthetic heart valve has a plurality of expandable and collapsible closed cells, a portion of which form an annulus section adapted for placement within the annulus of the native heart valve. Anchor features of the stent residing within at least some closed cells are adapted to engage tissue of the heart, including native valve leaflets, the sinotubular junction, or another implanted device when the prosthetic valve is implanted in the heart. The anchor features may help to retain the prosthetic valve in position, without interfering with the opening and closing of the valve leaflets. Furthermore, the anchor features may be configured to allow the stent to be resheathed into a delivery device after the portion of the stent with the anchor feature has expanded out of the delivery device.
Abstract: A stent deployment device comprises an elongate catheter shaft (2), and an inflatable balloon (3). The inflatable balloon (3) is movable between a collapsed configuration and an expanded configuration. In the expanded configuration part of the longitudinal axis of the balloon (3) is curved in three-dimensional space, and part of the balloon (3) is helically shaped. A stent (6) is movable from a collapsed delivery configuration to a partially expanded intermediate configuration, and subsequently from the intermediate configuration to a fully expanded deployed configuration. In the delivery configuration the longitudinal axis of the stent (6) is straight. The longitudinal axis of the stent (6) may be straight or curved in three-dimensional space in the intermediate configuration. In the deployed configuration the longitudinal axis of the stent (6) is curved in three-dimensional space. The balloon (3) in the expanded configuration exerts force on the stent (6).
Type:
Grant
Filed:
October 10, 2008
Date of Patent:
March 21, 2017
Inventors:
Kevin Heraty, Liam Mullins, Paul Gilson, Martin Burke
Abstract: Contact lenses incorporate mask lens designs that at least one of slow, retard or preventing myopia progression. The lens includes a first zone at a center of the lens; at least one peripheral zone surrounding the center and having a dioptric power that is different than that at the center; and an opaque mask beginning at a radial distance from the center, thereby providing a lens power profile having substantially equivalent foveal vision correction to a single vision lens, and having a depth of focus and reduced retinal image quality sensitivity that slows, retards, or prevents myopia progression.
Type:
Grant
Filed:
August 29, 2014
Date of Patent:
March 14, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Noel A. Brennan, Khaled A. Chehab, Xu Cheng, Kurt John Moody, Jeffrey H. Roffman, Xin Wei
Abstract: A device for implanting a prosthesis 12 in a body tissue equipped with a tubular element 7, within which a prosthesis 12 can slide, and a pressure element 16 for moving said prosthesis 12. The device also comprises a cartridge 5 provided with a seat 31 at its interior, such seat housing the prosthesis 12 and movable under the action of a pusher element 13 from a first position, in which the seat 31 is not facing the tubular element 7, to a second position, in which the seat 31 is in communication with the tubular element 7 in order to allow the insertion of the prosthesis 12 inside the tubular element 7 upon command of the pressure element 16.
Abstract: Aortic regurgitation can be treating by implanting in the aortic annulus a transvalvular intraannular band. The band has a first end, a first anchoring portion located proximate the first end, a second end, a second anchoring portion located proximate the second end, and a central portion. The central portion is positioned so that it extends transversely across a coaptive edge formed by the closure of the aortic valve leaflets. The band may be implanted via translumenal access or via thoracotomy.
Type:
Grant
Filed:
October 21, 2015
Date of Patent:
March 7, 2017
Assignee:
Heart Repair Technologies, Inc.
Inventors:
Valavanur A. Subramanian, Thomas Afzal, Gary Hulme, Jeffrey Christian, Michael L. Reo